Elisabeth Bjork's most recent trade in Rocket Pharmaceuticals Inc was a trade of 10,000 Common Stock done at an average price of $3.4 . Disclosure was reported to the exchange on Aug. 27, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Rocket Pharmaceuticals Inc | Elisabeth Bjork | Director | Purchase of securities on an exchange or from another person at price $ 3.41 per share. | 27 Aug 2025 | 10,000 | 40,000 (0%) | 0% | 3.4 | 34,100 | Common Stock |
| Rocket Pharmaceuticals Inc | Elisabeth Bjork | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 30,000 | 30,000 (0%) | 0% | 0 | Common Stock | |
| Rocket Pharmaceuticals Inc | Elisabeth Bjork | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Sep 2024 | 607 | 607 | - | - | Stock Option (Right to Buy) | |
| Rocket Pharmaceuticals Inc | Elisabeth Bjork | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 23,944 | 23,944 | - | - | Stock Option (Right to Buy) | |
| Rocket Pharmaceuticals Inc | Elisabeth Bjork | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 3,325 | 3,325 | - | - | Stock Option (Right to Buy) | |
| Rocket Pharmaceuticals Inc | Elisabeth Bjork | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 25,850 | 25,850 | - | - | Stock Option (Right to Buy) | |
| Rocket Pharmaceuticals Inc | Elisabeth Bjork | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 3,590 | 3,590 | - | - | Stock Option (Right to Buy) | |
| Rocket Pharmaceuticals Inc | Elisabeth Bjork | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2022 | 47,745 | 47,745 | - | - | Stock Option (Right to Buy) | |
| Rocket Pharmaceuticals Inc | Elisabeth Bjork | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2022 | 7,345 | 7,345 | - | - | Stock Option (Right to Buy) | |
| Rocket Pharmaceuticals Inc | Elisabeth Bjork | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2021 | 12,236 | 12,236 | - | - | Stock Option (Right to Buy) | |
| Rocket Pharmaceuticals Inc | Elisabeth Bjork | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2021 | 1,699 | 1,699 | - | - | Stock Option (Right to Buy) |